On 7/22/2003, Kryptiq of Oregon acquired RosettaMed for an undisclosed amount. RosettaMed develops and markets products to streamline the process of entering patient information into healthcare information systems. ramatically increase the utility, effectiveness, and acceptance of electronic medical records. RosettaMed facilitates data transfer among patients, physicians and electronic medical record (EMR) databases to improve healthcare communications, efficiency, outcomes, quality and satisfaction. The firm's flagship product, ChartCatalyst(tm), enables patients to complete questionnaires via a Web browser and their answers are transmitted to their physiciansâ Logician database in a controlled and authenticated fashion. The data are stored in a structured data format, without physician intervention. With ChartCatalyst(tm), the physician remains in complete control of the EMR. The Internet-based questionnaire can be accessed from the patientâs home, office, or while in the physicianâs waiting room. With no programming experience, and very little time, physicians can modify questions or create entirely new questionnaires -- in English or other languages, translating the responses to English for database storage. ChartCatalyst is optimized to work with Logician, with inbound and outbound interfaces present. ChartCatalyst helps physicians avoid data entry tasks that sometimes make EMR utilization painful. With ChartCatalyst, data are securely and accurately represented in the database, just as the patients entered their answers. RosettaMed maintains and updates standard database interfaces so clinics never need to worry about finding resources to create and implement interfaces. ChartCatalyst is a state-of-the-art solution to physicians' problem of getting patient data to the
